Galecto Research Development Over Time
| GLTO Stock | USD 26.24 1.14 4.54% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Galecto Performance and Galecto Correlation. Will Biotechnology sector continue expanding? Could Galecto diversify its offerings? Factors like these will boost the valuation of Galecto. Market participants price Galecto higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Galecto data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Galecto's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Research Development Analysis
Compare Galecto and related stocks such as Transcode Therapeutics, Phio Pharmaceuticals Corp, and Aprea Therapeutics Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RNAZ | 82.5 K | 82.5 K | 82.5 K | 82.5 K | 82.5 K | 82.5 K | 82.5 K | 82.5 K | 82.5 K | 226.3 K | 284.5 K | 2.8 M | 10.2 M | 12.3 M | 9.6 M | 11.1 M | 5.6 M |
| PHIO | 6.6 M | 6.6 M | 10.5 M | 17.7 M | 5.7 M | 6.9 M | 5.4 M | 5.4 M | 4.3 M | 4.3 M | 3.7 M | 8.9 M | 7 M | 6.3 M | 3.6 M | 3.3 M | 5.5 M |
| APRE | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 14.2 M | 21 M | 37.9 M | 23.9 M | 92.4 M | 7.6 M | 9.4 M | 10.8 M | 10.2 M |
| KPRX | 3 M | 3 M | 3 M | 1 M | 531.1 K | 2.7 M | 8.4 M | 10.3 M | 8.1 M | 5.4 M | 3.6 M | 5.4 M | 3.4 M | 4 M | 4.9 M | 5.6 M | 5.1 M |
| INAB | 581 K | 581 K | 581 K | 581 K | 581 K | 581 K | 581 K | 581 K | 581 K | 2.4 M | 5.4 M | 7.3 M | 14.1 M | 16.8 M | 17 M | 19.5 M | 10 M |
| ACXP | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 2.2 M | 2 M | 4.8 M | 6 M | 5.4 M | 6.2 M | 4.4 M |
| APVO | 38.1 M | 38.1 M | 38.1 M | 38.1 M | 46.6 M | 34.7 M | 29.5 M | 29 M | 35.4 M | 24.8 M | 17.9 M | 19 M | 17.9 M | 17.1 M | 14.4 M | 12.9 M | 21.6 M |
| LYRA | 5 M | 5 M | 5 M | 5 M | 5 M | 5 M | 5 M | 5 M | 5 M | 12 M | 12.5 M | 29.7 M | 38.8 M | 48 M | 43.8 M | 50.3 M | 29.8 M |
| ADIL | 322.1 K | 322.1 K | 322.1 K | 322.1 K | 322.1 K | 322.1 K | 146.1 K | 182.1 K | 368.5 K | 4 M | 5.9 M | 8.4 M | 2 M | 1.3 M | 3.2 M | 3.7 M | 2.8 M |
| BCDA | 215 K | 2.2 M | 2.2 M | 2.2 M | 1.5 M | 1.5 M | 3.3 M | 5.8 M | 8.5 M | 8.6 M | 9.8 M | 8.6 M | 8.8 M | 7.7 M | 4.4 M | 5 M | 5.4 M |
Galecto and related stocks such as Transcode Therapeutics, Phio Pharmaceuticals Corp, and Aprea Therapeutics Research Development description
My Equities
My Current Equities and Potential Positions
| Galecto | GLTO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Ole Maaloes Vej |
| Exchange | NASDAQ Exchange |
USD 26.24
Check out Galecto Performance and Galecto Correlation. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Galecto technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.